{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:51:03Z","timestamp":1761630663791,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ad.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T17:45:21Z","timestamp":1382118321000},"page":"520-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Angiosarcoma irresecable tratado con bevacizumab y paclitaxel"],"prefix":"10.1016","volume":"105","author":[{"given":"M.V.","family":"Nespereira-Jato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pe\u00f1a-Panabad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Quind\u00f3s-Varela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Garc\u00eda-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2013.08.006_bib0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","article-title":"Angiosarcoma","volume":"11","author":"Young","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ad.2013.08.006_bib0010","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mds237","article-title":"An open-label, multicenter, phase ii study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas","volume":"24","author":"Agulnik","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ad.2013.08.006_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ad.2011.10.014","article-title":"Angiosarcoma cut\u00e1neo tras radioterapia por c\u00e1ncer de mama","volume":"103","author":"Armengot-Carb\u00f3","year":"2012","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2013.08.006_bib0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.det.2011.01.004","article-title":"The role of radiation therapy in the management of skin cancers","volume":"29","author":"Hulyalkar","year":"2011","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ad.2013.08.006_bib0025","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jaad.2009.09.035","article-title":"Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy","volume":"63","author":"Fuller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2013.08.006_bib0030","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2146\/ajhp080455","article-title":"Understanding and managing the possible adverse effects associated with bevacizumab","volume":"66","author":"Shrod","year":"2009","journal-title":"Am J Health-Syst Pharm"},{"key":"10.1016\/j.ad.2013.08.006_bib0035","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/CCO.0b013e32833aaad4","article-title":"Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma\/solitary fibrous tumor","volume":"22","author":"Park","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ad.2013.08.006_bib0040","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/hed.20674","article-title":"Preoperative radiotherapy and bevacizumab for angiosarcoma of the head and neck: Two case studies","volume":"30","author":"Koontz","year":"2008","journal-title":"Head Neck"},{"key":"10.1016\/j.ad.2013.08.006_bib0045","first-page":"208","article-title":"Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face","volume":"163","author":"Ronsen","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2013.08.006_bib0050","doi-asserted-by":"crossref","first-page":"160369","DOI":"10.1155\/2011\/160369","article-title":"Scalp angiosarcoma remission with bevacizumab and radiotherapy without surgery: A case report and review of the literature","volume":"2011","author":"De Yao","year":"2011","journal-title":"Sarcoma"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013003153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013003153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:02:00Z","timestamp":1757552520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731013003153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0001731013003153"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2013.08.006","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiosarcoma irresecable tratado con bevacizumab y paclitaxel","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2013.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Espa\u00f1a, S.L. y AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}